StockNews.AI
ADI
StockNews.AI
209 days

Analog Devices Appoints Andrea F. Wainer to its Board of Directors

1. ADI appointed Andrea F. Wainer to its Board of Directors. 2. Wainer brings extensive healthcare leadership experience from Abbott and Pfizer. 3. Her expertise may enhance ADI's strategies in digital healthcare and diagnostics. 4. CEO Vincent Roche highlighted her influence in navigating opportunities for ADI. 5. Wainer's diverse background supports ADI's goal of bridging physical and digital worlds.

6m saved
Insight
Article

FAQ

Why Bullish?

Her appointment may lead to strategic growth in healthcare technologies, positively impacting ADI's market position similar to other tech firms benefitting from healthcare expertise.

How important is it?

Wainer's strong background in healthcare could significantly influence ADI's future innovations and market expansions.

Why Long Term?

Long-term impacts likely as Wainer influences ADI's strategic directions over time, akin to past board appointments driving innovation.

Related Companies

ABBVPFEADI
, /PRNewswire/ -- Analog Devices, Inc. (NASDAQ: ADI) today announced the appointment of Andrea F. Wainer, a seasoned healthcare executive, to its Board of Directors as an independent director. She will also serve as a member of the Board's Nominating and Corporate Governance Committee. Analog Devices appoints Andrea F. Wainer to its Board of Directors "We are delighted to welcome Andrea to the ADI Board, as her deep experience and leadership in the healthcare sector will provide ADI with an important source of wisdom and knowledge as we navigate the rich opportunity landscape ahead of us," said Vincent Roche, ADI's CEO and Chair. Wainer is a highly versatile, results-oriented leader with expertise leading innovative businesses at Abbott Laboratories (Abbott), Pfizer and Astellas Pharma. Since 2019, she has served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott. In this role, she leads three businesses – one focused on molecular diagnostics and the analysis of DNA and RNA at the molecular level, the second a provider of rapid point-of-care diagnostics, and the third delivers a leading hand-held point-of-care device. Previous roles held include President, Abbott Molecular Diagnostics; President, Abbott Animal Health; and Divisional Vice President/General Manager, Abbott Renal Care.Wainer also serves as a member of the Board of Trustees of the Goodman Theatre.She earned a Bachelor's Degree in Accounting from the John M. Olin School of Business, Washington University and a Master's Degree in Business Administration from the Kellogg School of Management, Northwestern University.About Analog Devices, Inc.Analog Devices, Inc. (NASDAQ: ADI) is a global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge. ADI combines analog, digital, and software technologies into solutions that help drive advancements in digitized factories, mobility, and digital healthcare, combat climate change, and reliably connect humans and the world. With revenue of more than $9 billion in FY24 and approximately 24,000 people globally, ADI ensures today's innovators stay Ahead of What's Possible. Learn more at www.analog.com and on LinkedIn and Twitter (X).All trademarks and registered trademarks are the property of their respective owners.CONTACT:Ferda MillanGlobal PR and External CommunicationsAnalog Devices[email protected](408) 373-1854 Michael LucarelliVice President, Investor Relations and FP&AAnalog Devices[email protected](781) 461-3282SOURCE Analog Devices, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News